Evidence map›Paper›PMID 41150682›Full record

ArticlePLoS biology2025

Mammalian antiviral proteins ZAP and KHNYN can independently restrict CpG-enriched avian viruses.

Jordan T Becker, Clayton K Mickelson, Lauren M Pross, Autumn E Sanders, Esther R Vogt, Frances K Shepherd, Chloe Wick, Alison J Barkhymer, Stephanie L Aron, Elizabeth J Fay and 2 more

Abstract read
In one paragraph

Article in PLoS biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. The potential impacts of human genetics on virus emergence.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Jordan T BeckerDepartment of Microbiology and Immunology, University of Minnesota-Twin Cities, Minneapolis, Minnesota, United States of America.
Clayton K MickelsonDepartment of Microbiology and Immunology, University of Minnesota-Twin Cities, Minneapolis, Minnesota, United States of America.
Lauren M ProssDepartment of Microbiology and Immunology, University of Minnesota-Twin Cities, Minneapolis, Minnesota, United States of America.
Autumn E SandersDepartment of Microbiology and Immunology, University of Minnesota-Twin Cities, Minneapolis, Minnesota, United States of America.
Esther R VogtDepartment of Microbiology and Immunology, University of Minnesota-Twin Cities, Minneapolis, Minnesota, United States of America.
Frances K ShepherdDepartment of Microbiology and Immunology, University of Minnesota-Twin Cities, Minneapolis, Minnesota, United States of America.
Chloe WickDepartment of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota-Twin Cities, Minneapolis, Minnesota, United States of America.
Alison J BarkhymerDepartment of Microbiology and Immunology, University of Minnesota-Twin Cities, Minneapolis, Minnesota, United States of America.
Stephanie L AronDepartment of Microbiology and Immunology, University of Minnesota-Twin Cities, Minneapolis, Minnesota, United States of America.
Elizabeth J FayDepartment of Microbiology and Immunology, University of Minnesota-Twin Cities, Minneapolis, Minnesota, United States of America.
Reuben S HarrisDepartment of Biochemistry and Structural Biology, University of Texas Health, San Antonio, Texas, United States of America.
Ryan A LangloisDepartment of Microbiology and Immunology, University of Minnesota-Twin Cities, Minneapolis, Minnesota, United States of America.

Funding

NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities75N93021C00017 · NIAID · EMORY UNIVERSITY · PI LOWEN, ANICE · 2021 to 2025
$27.3M
Early Responses to Influenza A Virus Replication In VivoR01AI148669 · NIAID · UNIVERSITY OF MINNESOTA · PI LANGLOIS, RYAN · 2020 to 2024
$2.5M
Harnessing ZBP1-driven cell death to improve influenza vaccine efficacyR56AI150965 · NIAID · RESEARCH INST OF FOX CHASE CAN CTR · PI BALACHANDRAN, SIDDHARTH, LANGLOIS, RYAN · 2021 to 2021
$848k
APOBEC PROTEINS AND RIBOVIRAL RESTRICTIONF32AI147813 · NIAID · UNIVERSITY OF MINNESOTA · PI BECKER, JORDAN T · 2019 to 2021
$192k
NIAID NIH HHS 75N93021C00017NIAID NIH HHS F32 AI147813NIAID NIH HHS R01 AI148669NIAID NIH HHS R56 AI150965
6 · The paper itself

Abstract

Zoonotic viruses are an omnipresent threat to global health. Influenza A virus (IAV) transmits between birds, livestock, and humans. Proviral host factors involved in the cross-species interface are well known. Less is known about antiviral mechanisms that suppress IAV zoonoses. We observed CpG dinucleotide depletion in human IAV relative to avian IAV. Notably, human ZAP selectively depletes CpG-enriched viral RNAs with its cofactor KHNYN. ZAP is conserved in tetrapods, but we uncovered that avian species lack KHNYN. We found that chicken ZAP may not affect IAV (PR8) or CpG-enriched IAV (PR8CG). Human ZAP or KHNYN independently restricted CpG-enriched IAV PR8CG by overexpression in chicken cells and by combined knockout in human cells. Additionally, mammalian ZAP-L and KHNYN also independently restricted an avian retrovirus (ROSV). Curiously, platypus KHNYN, the most divergent from eutherian mammals, was also capable of independent restriction of multiple diverse viruses. We suggest that some mammalian KHNYN can act as a bona fide restriction factor with cell-autonomous activity. Furthermore, we speculate that through repeated contact between avian viruses and mammalian hosts, protein changes may accompany CpG-biased mutations or reassortment to evade mammalian ZAP and KHNYN.

Indexed as

CpG IslandsInfluenza A virusRNA-Binding ProteinsZAP-70 Protein-Tyrosine KinaseAnimalsBirdsChickensHEK293 CellsHumansInfluenza in BirdsRNA, ViralRNA-Binding ProteinsRNA, ViralZAP-70 Protein-Tyrosine KinaseZC3HAV1 protein, human

Identifiers

PMID41150682
PMCPMC12582503

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.